Codexis (CDXS) Net Margin (2010 - 2026)

Codexis' (CDXS) quarterly Net Margin came in at 57.08% in Q1 2026, up 21718.0% year-on-year from N/an in Q1 2025, and down 331.37% quarter-over-quarter from 24.67% in Q4 2025.

Codexis (CDXS) Net Margin (2010 - 2026) Analysis & Trends

Codexis' Net Margin history runs 17 years deep, the most recent figure standing at 57.08% for Q1 2026.

  • On a quarterly basis, Net Margin rose 21718.0% year-over-year to 57.08% in Q1 2026; TTM through Mar 2026 was 40.96%, a 10851.0% increase from a year earlier, with the FY2025 full-year figure at 62.47%, up 4752.0% from the prior year.
  • Net Margin fell to 57.08% in Q1 2026 per CDXS's latest filing, from 24.67% in the prior quarter.
  • Across five years, Net Margin topped out at 24.67% in Q4 2025 and bottomed at 376.29% in Q3 2023.
  • The 5-year median for Net Margin is 86.59% (2025), against an average of 131.24%.
  • Across the five-year window, Net Margin slumped 34730 bps in 2023 and soared 21718 bps in 2026, its largest moves.
  • Year by year, Net Margin stood at 63.66% in 2022, then slumped by 126 bps to 143.84% in 2023, then jumped by 66 bps to 48.35% in 2024, then jumped by 151 bps to 24.67% in 2025, then slumped by 331 bps to 57.08% in 2026.
  • Per Business Quant, the three latest CDXS Net Margin figures stand at 57.08% (Q1 2026), 24.67% (Q4 2025), and 228.05% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn 15.02%
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 20.17%
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn 30.33%
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 17.65%
10 Codexis 137.51 Mn 72.37 Mn 13.18 Mn -57.08%

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.08%
Dec 31, 2025 24.67%
Sep 30, 2025 -228.05%
Jun 30, 2025 -86.59%
Mar 31, 2025 -274.27%
Dec 31, 2024 -48.35%
Sep 30, 2024 -160.84%
Jun 30, 2024 -285.19%
Mar 31, 2024 -67.39%
Dec 31, 2023 -143.84%
Sep 30, 2023 -376.29%
Jun 30, 2023 -230.46%
Mar 31, 2023 -174.22%
Dec 31, 2022 -63.66%
Sep 30, 2022 -28.99%
Jun 30, 2022 -6.87%
Mar 31, 2022 -23.64%
Dec 31, 2021 -41.59%
Sep 30, 2021 6.10%
Jun 30, 2021 -16.76%